Get the Stockscreener App
9.20
0.65%
-0.06
After Hours:
9.20
Prothena Corporation Plc stock is traded at $9.20, with a volume of 340.98K.
It is down -0.65% in the last 24 hours and down -33.04% over the past month.
See More
Previous Close:
$9.26
Open:
$9.17
24h Volume:
340.98K
Relative Volume:
0.80
Market Cap:
$535.04M
Revenue:
$217.25M
Net Income/Loss:
$-50.92M
P/E Ratio:
-9.20
EPS:
-1
Net Cash Flow:
$-100.85M
1W Performance:
-5.06%
1M Performance:
-33.04%
6M Performance:
-46.07%
1Y Performance:
-56.19%
1-Day Range:
$9.10
$9.485
1-Week Range:
$9.10
$10.45
52-Week Range:
$9.10
$25.42
Prothena Corporation Plc Stock (PRTA) Company Profile
Name
Prothena Corporation Plc
Sector
Industry
Phone
011-353-1-236-2500
Address
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
9.20 | 535.04M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Jan-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Apr-24-23 | Initiated | SVB Securities | Outperform |
| Jan-27-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-28-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-18-21 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-08-21 | Reiterated | Oppenheimer | Outperform |
| May-26-21 | Initiated | Citigroup | Buy |
| Feb-26-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-12-21 | Upgrade | Jefferies | Hold → Buy |
| Feb-02-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-07-20 | Initiated | H.C. Wainwright | Buy |
| Jul-09-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-19-19 | Upgrade | Evercore ISI | In-line → Outperform |
| May-21-18 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-23-18 | Downgrade | Jefferies | Buy → Hold |
| Apr-05-18 | Reiterated | Barclays | Overweight |
| Nov-20-17 | Downgrade | Wedbush | Outperform → Neutral |
| Sep-29-17 | Reiterated | BTIG Research | Buy |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Aug-17-17 | Initiated | Evercore ISI | Outperform |
| Jul-11-17 | Initiated | Jefferies | Buy |
| Apr-12-17 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-12-17 | Initiated | Piper Jaffray | Overweight |
| Mar-02-17 | Initiated | Instinet | Buy |
| Dec-21-16 | Initiated | SunTrust | Buy |
| Nov-03-16 | Initiated | Deutsche Bank | Buy |
| Aug-04-16 | Reiterated | Barclays | Overweight |
| May-13-16 | Initiated | Barclays | Overweight |
| Feb-19-16 | Reiterated | Wedbush | Outperform |
| Jan-21-16 | Initiated | Credit Suisse | Outperform |
View All
Prothena Corporation Plc Stock (PRTA) Latest News
19,687 Shares in Prothena Co. plc (NASDAQ:PRTA) Bought by Franklin Resources Inc. - Defense World
JPMorgan Chase & Co. Purchases 187,364 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
(PRTA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Vanguard Group Inc. Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Bought by American Century Companies Inc. - Defense World
Norges Bank Invests $796,000 in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Raymond James Financial Inc. Acquires New Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Corebridge Financial Inc. Sells 1,596 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
KLP Kapitalforvaltning AS Purchases Shares of 12,900 Prothena Co. plc (NASDAQ:PRTA) - Defense World
Thrivent Financial for Lutherans Sells 8,889 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Teacher Retirement System of Texas Purchases Shares of 10,434 Prothena Co. plc (NASDAQ:PRTA) - Defense World
Benign Growth For Prothena Corporation plc (NASDAQ:PRTA) Underpins Stock's 26% Plummet - simplywall.st
Chardan Capital Predicts Prothena FY2025 Earnings - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Amundi Has $28,000 Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
(PRTA) Technical Data - news.stocktradersdaily.com
Bank of New York Mellon Corp Has $2.08 Million Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Analysts Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00 - The AM Reporter
Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00 - Defense World
What is Zacks Research’s Forecast for Prothena Q1 Earnings? - The AM Reporter
Zacks Research Has Positive Outlook of Prothena Q1 Earnings - Defense World
Insider Sell: Chief Medical Officer Hideki Garren Sells 2,000 Sh - GuruFocus.com
Zacks Research Weighs in on Prothena FY2027 Earnings - Defense World
Trend Tracker for (PRTA) - Stock Traders Daily
Recent Analysts’ Ratings Changes for Prothena (PRTA) - Defense World
Rhumbline Advisers Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Handelsbanken Fonder AB - Defense World
Prothena Corporation: Multiple Failures Make It Risky (NASDAQ:PRTA) - Seeking Alpha
Prothena (NASDAQ:PRTA) Price Target Raised to $110.00 - The AM Reporter
Prothena (NASDAQ:PRTA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World
PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView
Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus - MSN
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential By Investing.com - Investing.com South Africa
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential - Investing.com India
Prothena (NASDAQ:PRTA) Rating Increased to Hold at StockNews.com - Defense World
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga
Prothena’s (PRTA) “Buy” Rating Reiterated at HC Wainwright - Defense World
Prothena’s (PRTA) “Buy” Rating Reiterated at Chardan Capital - Defense World
Analysts Set Prothena Co. plc (NASDAQ:PRTA) PT at $46.50 - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for Prothena (NASDAQ:PRTA) - Defense World
Royal Bank of Canada Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock Price - Defense World
Prothena Corporation plc (NASDAQ:PRTA) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St
Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript - Insider Monkey
RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk - Marketscreener.com
Prothena Corporation (NASDAQ: PRTA) Gears Up for Transformational 2025 with Key Clinical Milestones - Pradesh Tak
Earnings call transcript: Prothena's Q4 2024 results highlight innovation By Investing.com - Investing.com Australia
Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ... - Yahoo Finance
Earnings call transcript: Prothena's Q4 2024 results highlight innovation - Investing.com
Prothena: Q4 Earnings Snapshot -February 20, 2025 at 04:23 pm EST - Marketscreener.com
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights - Business Wire
Prothena Corporation Plc Stock (PRTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):